IMCAS - Congresses on Dermatology and Aesthetic & Plastic Surgery

239 Updated and future aesthetic toxins

samedi 03 février 2024

14:00 to 15:30

Amphi Havane - Level 3

SESSION SCIENTIFIQUE

Modérateur(s)

Dr Benjamin ASCHER

Chirurgien Plasticien

France

Prof Mark Steven NESTOR

Dermatologue

États-Unis

Présentations de la session

14:00

Introduction

14:03

PART 1 - 2024 update on novel toxins

14:03

Jon EDELSON

Update on Eirion’s topical and liquid injectable botulinum

14:12

Dr Rui AVELAR

PrabotulinumtoxinA 40U long-duration formulation, phase II study final results - Evolus

14:21

Mickael MACHICOANE

Fast onset, long duration: “I want it all”? - Fastox

14:30

Xiaoming LIN

RelabotulinumtoxinA – Innovation From Lab to Clinic - Galderma

14:39

Dr Conor GALLAGHER

DaxibotulinumtoxinA: an update from Revance

14:48

Panel discussion

14:58

PART 2 - New toxins from Asia

14:58

Dr Choon Shik YOON

The pioneer and innovator: Asia's first FDA-approved Botulinum Toxin, Prabotulinumtoxin A - New indication introduction - Daewoong

15:08

Hyoung Jin MOON

New clinical evidence of LetibotulinumtoxinA: beyond Asia to the world - Hugel

15:18

Panel discussion & closing

15:28

Conclusion

Sessions à ne pas manquer

Toxins 237, 238

Industrie Symposium

ULTRA V Symposium - PDO microsphere liquid for lifting and collagen bio - stimulator 243

Medical rhinoplasty 199

Holistic approach in facial rejuvenation - Sinophone Masterclass 226

Industrie Symposium

VAIM Symposium - A New Era in Anti-Aging with New Collagen Boosters Using PDLLA + HA, JUVELOOK and LENISNA 220

Vous avez une question ?

Attention

Modérateur(s)

Présentations de la session

Sessions à ne pas manquer

Vous avez une question ?

Erreur